Jiangsu Sihuan Bioengineering Co Ltd
SZSE:000518
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
J
|
Jiangsu Sihuan Bioengineering Co Ltd
SZSE:000518
|
CN |
Balance Sheet
Balance Sheet Decomposition
Jiangsu Sihuan Bioengineering Co Ltd
Jiangsu Sihuan Bioengineering Co Ltd
Balance Sheet
Jiangsu Sihuan Bioengineering Co Ltd
| Dec-2001 | Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
298
|
352
|
395
|
388
|
306
|
194
|
75
|
65
|
71
|
135
|
201
|
196
|
140
|
35
|
24
|
65
|
41
|
39
|
53
|
55
|
38
|
28
|
15
|
8
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
1
|
0
|
5
|
0
|
0
|
0
|
0
|
38
|
28
|
15
|
8
|
|
| Cash Equivalents |
298
|
352
|
395
|
388
|
306
|
194
|
75
|
65
|
71
|
135
|
201
|
195
|
139
|
34
|
24
|
60
|
41
|
39
|
53
|
54
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
136
|
112
|
150
|
254
|
240
|
248
|
259
|
146
|
93
|
91
|
196
|
152
|
89
|
123
|
177
|
142
|
141
|
139
|
141
|
157
|
142
|
119
|
77
|
74
|
|
| Accounts Receivables |
72
|
87
|
101
|
129
|
157
|
160
|
152
|
85
|
79
|
84
|
82
|
94
|
73
|
84
|
99
|
117
|
112
|
130
|
127
|
145
|
136
|
106
|
73
|
66
|
|
| Other Receivables |
64
|
26
|
49
|
125
|
83
|
88
|
107
|
61
|
14
|
8
|
114
|
58
|
16
|
39
|
78
|
25
|
29
|
10
|
14
|
12
|
6
|
14
|
4
|
8
|
|
| Inventory |
193
|
185
|
165
|
154
|
117
|
180
|
143
|
59
|
191
|
42
|
43
|
33
|
48
|
42
|
212
|
462
|
584
|
581
|
557
|
449
|
431
|
409
|
409
|
360
|
|
| Other Current Assets |
70
|
24
|
25
|
49
|
71
|
43
|
5
|
146
|
54
|
88
|
66
|
76
|
173
|
148
|
30
|
7
|
4
|
4
|
5
|
8
|
9
|
9
|
9
|
4
|
|
| Total Current Assets |
697
|
674
|
736
|
845
|
734
|
665
|
481
|
416
|
410
|
356
|
506
|
456
|
450
|
349
|
443
|
676
|
770
|
763
|
756
|
669
|
620
|
565
|
509
|
447
|
|
| PP&E Net |
232
|
295
|
321
|
340
|
433
|
420
|
317
|
269
|
267
|
251
|
247
|
250
|
237
|
330
|
304
|
245
|
85
|
90
|
81
|
85
|
92
|
85
|
84
|
75
|
|
| PP&E Gross |
232
|
295
|
321
|
340
|
433
|
420
|
317
|
269
|
267
|
251
|
247
|
250
|
237
|
330
|
304
|
245
|
85
|
90
|
81
|
85
|
92
|
85
|
84
|
75
|
|
| Accumulated Depreciation |
29
|
29
|
45
|
60
|
71
|
101
|
77
|
93
|
105
|
111
|
49
|
65
|
79
|
92
|
104
|
120
|
81
|
87
|
99
|
102
|
108
|
121
|
134
|
144
|
|
| Intangible Assets |
150
|
163
|
161
|
149
|
80
|
88
|
52
|
43
|
27
|
169
|
172
|
162
|
98
|
102
|
59
|
69
|
46
|
40
|
50
|
44
|
41
|
47
|
30
|
11
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
49
|
12
|
0
|
0
|
0
|
6
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
3
|
13
|
12
|
18
|
15
|
8
|
20
|
48
|
46
|
182
|
27
|
26
|
26
|
25
|
24
|
23
|
22
|
23
|
22
|
21
|
39
|
36
|
33
|
29
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
38
|
34
|
0
|
0
|
0
|
4
|
4
|
11
|
12
|
12
|
13
|
5
|
4
|
9
|
10
|
7
|
5
|
6
|
5
|
5
|
5
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
49
|
12
|
0
|
0
|
0
|
6
|
6
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
1 082
N/A
|
1 145
+6%
|
1 230
+7%
|
1 389
+13%
|
1 296
-7%
|
1 229
-5%
|
883
-28%
|
776
-12%
|
753
-3%
|
962
+28%
|
970
+1%
|
913
-6%
|
823
-10%
|
818
-1%
|
835
+2%
|
1 017
+22%
|
932
-8%
|
926
-1%
|
916
-1%
|
824
-10%
|
799
-3%
|
738
-8%
|
661
-10%
|
567
-14%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
16
|
22
|
26
|
27
|
22
|
25
|
11
|
8
|
14
|
13
|
13
|
17
|
15
|
26
|
84
|
313
|
19
|
61
|
63
|
58
|
61
|
53
|
50
|
61
|
|
| Accrued Liabilities |
35
|
33
|
28
|
47
|
37
|
32
|
19
|
8
|
9
|
11
|
10
|
13
|
10
|
8
|
9
|
12
|
8
|
9
|
10
|
10
|
12
|
15
|
13
|
13
|
|
| Short-Term Debt |
3
|
3
|
52
|
192
|
212
|
132
|
2
|
52
|
2
|
0
|
0
|
0
|
0
|
0
|
35
|
53
|
50
|
70
|
16
|
16
|
16
|
16
|
16
|
13
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
10
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
4
|
5
|
6
|
|
| Other Current Liabilities |
44
|
24
|
28
|
16
|
21
|
28
|
16
|
13
|
15
|
57
|
29
|
49
|
52
|
56
|
81
|
27
|
177
|
143
|
164
|
54
|
28
|
28
|
33
|
42
|
|
| Total Current Liabilities |
99
|
82
|
134
|
282
|
292
|
217
|
48
|
81
|
40
|
82
|
52
|
79
|
85
|
92
|
209
|
405
|
254
|
283
|
254
|
138
|
121
|
116
|
118
|
134
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
31
|
28
|
26
|
21
|
|
| Minority Interest |
3
|
4
|
4
|
4
|
3
|
6
|
5
|
4
|
0
|
163
|
205
|
84
|
56
|
41
|
2
|
0
|
47
|
44
|
47
|
44
|
41
|
36
|
31
|
27
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
3
|
0
|
1
|
2
|
3
|
5
|
5
|
17
|
1
|
2
|
0
|
2
|
1
|
1
|
0
|
4
|
14
|
|
| Total Liabilities |
102
N/A
|
86
-16%
|
138
+61%
|
286
+107%
|
296
+3%
|
224
-24%
|
54
-76%
|
87
+60%
|
40
-54%
|
246
+509%
|
260
+6%
|
167
-36%
|
148
-12%
|
137
-7%
|
228
+66%
|
406
+78%
|
303
-25%
|
327
+8%
|
302
-7%
|
183
-39%
|
193
+6%
|
181
-6%
|
179
-1%
|
196
+9%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
179
|
515
|
1 030
|
1 030
|
1 030
|
1 030
|
1 030
|
1 030
|
1 030
|
1 030
|
1 030
|
1 030
|
1 030
|
1 030
|
1 030
|
1 030
|
1 030
|
1 030
|
1 030
|
1 030
|
1 030
|
1 030
|
1 030
|
1 030
|
|
| Retained Earnings |
72
|
139
|
60
|
71
|
33
|
25
|
202
|
341
|
318
|
314
|
320
|
310
|
381
|
375
|
449
|
445
|
437
|
467
|
453
|
425
|
460
|
509
|
584
|
694
|
|
| Additional Paid In Capital |
729
|
405
|
3
|
3
|
3
|
1
|
1
|
1
|
1
|
1
|
1
|
26
|
26
|
25
|
25
|
25
|
36
|
36
|
36
|
36
|
36
|
36
|
36
|
36
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
1
|
|
| Total Equity |
980
N/A
|
1 059
+8%
|
1 092
+3%
|
1 103
+1%
|
1 000
-9%
|
1 006
+1%
|
829
-18%
|
689
-17%
|
712
+3%
|
716
+1%
|
710
-1%
|
746
+5%
|
675
-9%
|
681
+1%
|
607
-11%
|
611
+1%
|
629
+3%
|
599
-5%
|
614
+2%
|
641
+4%
|
606
-5%
|
557
-8%
|
482
-14%
|
372
-23%
|
|
| Total Liabilities & Equity |
1 082
N/A
|
1 145
+6%
|
1 230
+7%
|
1 389
+13%
|
1 296
-7%
|
1 229
-5%
|
883
-28%
|
776
-12%
|
753
-3%
|
962
+28%
|
970
+1%
|
913
-6%
|
823
-10%
|
818
-1%
|
835
+2%
|
1 017
+22%
|
932
-8%
|
926
-1%
|
916
-1%
|
824
-10%
|
799
-3%
|
738
-8%
|
661
-10%
|
567
-14%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
1 030
|
1 030
|
1 030
|
1 030
|
1 030
|
1 030
|
1 030
|
1 030
|
1 030
|
1 030
|
1 030
|
1 030
|
1 030
|
1 030
|
1 030
|
1 030
|
1 030
|
1 030
|
1 030
|
1 030
|
1 030
|
1 030
|
1 030
|
1 030
|
|